Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2975
Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report
Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Constance Albarracin
Constance Albarracin
Associate Professor
University of Texas MD Anderson Cancer Centre
USA
Biography
Dr. Constance Albarracin, MD, Ph.D. is a surgical pathologist and tenured professor at MD Anderson Cancer Center, Houston. She completed her pathology residency training at the University of Chicago Medical School, her MD degree from the University of Santo Tomas in the Philippines and her PhD degree in Physiology at the University of Illinois in Chicago. Dr. Albarracin did her postdoctoral fellowship at the Brigham and Women\s Hospital, Harvard Medical School. She subspecialized in Breast and Gynecologic Pathology at the Beth Israel Hospital in Boston and at MD Anderson Cancer Center. Currently an Associate Professor at University of Texas M.D. Anderson, she has developed her research with BRCA-associated cancers and the role of microRNAs in breast and uterine cancer progression.
Research Interest
BRCA associated cancers, breast cancer and uterine cancer progression.
Certificate
Global Speakers in the subject
Global Experts in the subject
Publications
Evolving Role of Ki67 as a Predictive and Prognostic Marker in Breast Cancer
| Constance Albarracin and Sagar Dhamn |
| Editorial: J Clin Exp Pathol 2014, 4: e119 |
| DOI: 10.4172/2161-0681.1000e119 |
